697-706
Review Article
Erosive osteoarthritis: a current review of a clinical challenge
Sharon E. Banks
707-716
Review Article
Off-label use of rituximab in systemic lupus erythematosus: a systematic review
Eleanor Murray and Martin Perry
717-721
Original Article
Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients
Dawei Hu, Xiaoqian Liu, Shunle Chen and Chunde Bao
723-727
Original Article
Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab
Herwig Pieringer, Ulrike Stuby, Erich Pohanka and Georg Biesenbach
729-737
Original Article
Renal disease in systemic sclerosis with normal serum creatinine
Reem H. A. Mohamed, Hania S. Zayed and Amr Amin
739-747
Original Article
Open AccessOsteoarthritis of the hip or knee: which coexisting disorders are disabling?
Kerstin G. Reeuwijk, Mariëtte de Rooij, Gabriella M. van Dijk, Cindy Veenhof and Martijn P. Steultjens, et al.
749-756
Original Article
Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritis
Sibel Basaran, Rengin Guzel, Gulsah Seydaoglu and Fusun Guler-Uysal
757-761
Original Article
Juvenile idiopathic arthritis among Nigerians: a case study
Olufemi O. Adelowo and A. Umar
763-770
Original Article
Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade
Ashit Syngle, Kanchan Vohra, Anjali Sharma and L. Kaur
771-775
Original Article
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
Meng-Yu Weng, Chia-Tse Weng and Ming-Fei Liu
777-779
Brief Report
Reinforcing a medical hypothesis with a new question: is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA?
Fabricio Souza Neves, Thais Helena Otto da Silva, Gislaine Paviani, Adriana Fontes Zimmermann and Glaucio Ricardo Werner de Castro, et al.
781-788
Brief Report
Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis
Samira Rostom, Karima Benbouaaza, Bouchra Amine, Rachid Bahiri and Yousra Ibn Yacoub, et al.
789-791
Case Report
Primary Sjogren’s syndrome with anticentromere antibodies—a clinically distinct subset
Dhiraj Gulati, Irving Kushner, Elizabeth File and Marina Magrey
793-794
Case Report
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis
Gleb Slobodin, Itzhak Rosner, Doron Rimar, Nina Boulman and Michael Rozenbaum, et al.
795-797
Case Report
Adult presentation of Stickler syndrome type III
Kayi Li and Carter Thorne
799-801
Case Report
Diffuse systemic sclerosis and autoimmune hepatitis: a unique association
Carlos Ewerton Maia Rodrigues, Cláudia Lobato Borges and Jozélio Freire de Carvalho
803-805
Case Report
Exertional paraspinal muscle rhabdomyolysis and compartment syndrome: a cause of back pain not to be missed
Lori Wik, Jeffrey M. Patterson and Anna E. Oswald
807-809
Case Report
A case of Hughes–Stovin syndrome associated with hyperhomocysteinemia
Hyun-Ok Kim, Ho Cheol Kim, Yongwhi Park, Yong-Geun Jeong and Jae Hee Kim, et al.
811-814
Case Report
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis
Melinda Vincze, Peter A. Molnár, Judit Tumpek, Lászlóné Szőllősi and Ágnes Gyetvai, et al.
815-818
Case Report
Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report
Megha S. Uppin, Liza Rajasekhar, H. Swetha, V. R. Srinivasan and Aruna K. Prayaga
819-820
Letter to Editor
Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?
Takao Nagashima and Seiji Minota
821
Erratum
Erratum to: Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee
Karel Pavelka, Philippe Coste, Pál Géher and Gerhard Krejci